1 |
Nakano, T., Ohara, O., Teraoka, H. and Arita, H. (1990) Glucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J. Biol. Chem. 265, 12745-12748.
|
2 |
Pruzanski, W. and Vadas, P. (1991) Phospholipase A2--a mediator between proximal and distal effectors of inflammation. Immunol. Today 12, 143-146.
|
3 |
Bradley, J. D., Dmitrienko, A. A., Kivitz, A. J., Gluck, O. S., Weaver, A. L., Wiesenhutter, C., Myers, S. L. and Sides, G. D. (2005) A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J. Rheumatol. 32, 417-423.
DOI
|
4 |
Zeiher, B. G., Steingrub, J., Laterre, P. F., Dmitrienko, A., Fukiishi, Y. and Abraham, E. (2005) LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit. Care Med. 33, 1741-1748.
DOI
ScienceOn
|
5 |
Yamauchi, T., Umeda, F., Inoguchi, T. and Nawata, H. (1989) Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem. Biophys Res. Commun 163, 1404-1411.
DOI
ScienceOn
|
6 |
Hoffmann, J. N., Vollmar, B., Romisch, J., Inthorn, D., Schildberg, F. W. and Menger, M. D. (2002) Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit. Care Med. 30, 218-225.
DOI
ScienceOn
|
7 |
Kaneider, N. C., Reinisch, C. M., Dunzendorfer, S., Romisch, J. and Wiedermann, C. J. (2002) Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J. Cell Sci. 115, 227-236.
|
8 |
Menschikowski, M., Hagelgans, A., Hempel, U., Lattke, P., Ismailov, I. and Siegert, G. (2008) On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A2 expression. Thromb. Res. 122, 69-76.
DOI
ScienceOn
|
9 |
Bae, J. S. and Rezaie, A. R. (2010) Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms. Thromb. Res. 125, e9-e15.
DOI
ScienceOn
|
10 |
Sonoki, K., Iwase, M., Sasaki, N., Ohdo, S., Higuchi, S., Takata, Y. and Iida, M. (2008) Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells. Br. J. Pharmacol. 153, 1399-1408.
DOI
ScienceOn
|
11 |
Hayashi, H., Tsuchiya, Y., Nakayama, K., Satoh, T. and Nishida, E. (2008) Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling. Genes Cells 13, 941-947.
DOI
ScienceOn
|
12 |
Yao, R. and Cooper, G. M. (1995) Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
DOI
|
13 |
Crowl, R. M., Stoller, T. J., Conroy, R. R. and Stoner, C. R. (1991) Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266, 2647-2651.
|
14 |
Minshall, C., Arkins, S., Freund, G. G. and Kelley, K. W. (1996) Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156, 939-947.
|
15 |
Ahmed, N. N., Grimes, H. L., Bellacosa, A., Chan, T. O. and Tsichlis, P. N. (1997) Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. U.S.A. 94, 3627-3632.
DOI
|
16 |
Bae, J. S., Kim, Y. U., Park, M. K. and Rezaie, A. R. (2009) Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase. J. Cell Physiol. 219, 744-751.
DOI
ScienceOn
|
17 |
Oka, S. and Arita, H. (1991) Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem. 266, 9956-9960.
|
18 |
Marcum, J. A. and Rosenberg, R. D. (1984) Anticoagulantly active heparin-like molecules from vascular tissue. Biochemistry 23, 1730-1737.
DOI
ScienceOn
|
19 |
Kaneider, N. C., Egger, P., Dunzendorfer, S. and Wiedermann, C. J. (2001) Syndecan-4 as antithrombin receptor of human neutrophils. Biochem. Biophys. Res. Commun. 287, 42-46.
DOI
ScienceOn
|
20 |
Parrillo, J. E. (1993) Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328, 1471-1477.
DOI
ScienceOn
|
21 |
Bass, M. D. and Humphries, M. J. (2002) Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling. Biochem. J. 368, 1-15.
DOI
ScienceOn
|
22 |
Menschikowski, M., Hagelgans, A. and Siegert, G. (2006) Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases? Prostaglandins. Other. Lipid. Mediat. 79, 1-33.
DOI
ScienceOn
|
23 |
Delehedde, M., Lyon, M., Sergeant, N., Rahmoune, H. and Fernig, D. G. (2001) Proteoglycans: pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J. Mammary. Gland. Biol. Neoplasia. 6, 253-273.
DOI
ScienceOn
|
24 |
Kaneider, N. C., Forster, E., Mosheimer, B., Sturn, D. H. and Wiedermann, C. J. (2003) Syndecan-4-dependent signaling in the inhibition of endotoxin-induced endothelial adherence of neutrophils by antithrombin. Thromb. Haemost. 90, 1150-1157.
|
25 |
Bae, J. S. and Rezaie, A. R. (2009) Mutagenesis studies toward understanding the intracellular signaling mechanism of antithrombin. J. Thromb. Haemost. 7, 803-810.
DOI
ScienceOn
|
26 |
Kudo, I. and Murakami, M. (2002) Phospholipase A2 enzymes. Prostaglandins. Other. Lipid. Mediat. 68-69, 3-58.
DOI
ScienceOn
|